Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
JAMA Cardiology Author Interviews
00:00
Population Impact and Treatment Gaps
Bach highlights population demographics, high cardiovascular mortality in ≥75, and underuse of intensive lipid lowering.
Play episode from 23:59
Transcript
